Skip to main content

Currently Skimming:

Appendix E: Forum Member Biographies
Pages 437-464

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 437...
... from Harvard Medical School (1982) , completed his clinical training in internal medicine and infectious diseases at Massachusetts General Hospital, served as a postdoctoral fellow in microbiology at Stanford University, and joined the faculty at Stanford in 1994.
From page 438...
... Hughes' career is on building partnerships among the clinical, research, public health, and veterinary communities to prevent and respond to infectious diseases at the national and global levels. His research interests include emerging and reemerging infectious diseases, antimicrobial resistance, foodborne
From page 439...
... In 2001 she came to her current position at Emory University, directing a center focused on emerg ing infectious diseases and other urgent threats to health, including terrorism. She has also consulted with the biologic program of the Nuclear Threat Initiative and is most recognized for her work in infectious diseases and disease surveillance.
From page 440...
... defense against natural and deliberate infection with these agents and led to his involvement in the early 1990s in biological weapons defense and proliferation prevention. From 1995 to 1998, he directed research programs in 20 laboratories in the Southeast for USDA's Agricultural Research Service before going to Washington, DC, to establish biological weapons defense research programs for USDA.
From page 441...
... patents, has published over 30 peer-reviewed scientific papers, and has given 25 invited speaker presentations; he has been a member of the IOM Forum on Microbial Threats since 1997. In February 2009, he established SJ Brickner Consulting, LLC, which serves various clients in offering consulting services on all aspects of medicinal chemistry and drug design related to the discovery and development of new antibiotics.
From page 442...
... For 9 years she was chairman of the Public and Scientific Affairs Board of the ASM; she has served as an adviser on infectious diseases and indirect costs of research to the White House Office of Science and Technology Policy; and she has been an invited participant in numerous congressional hearings and briefings related to infectious diseases, antimicrobial resistance, and biomedical research. She has served two terms on the Liaison Committee for Medical Education, the accrediting body for U.S.
From page 443...
... Epidemic Intelligence Service, assigned to the National Center for Infectious Diseases. He subsequently worked for CDC as a medical epidemiologist in the Divisions of Tuberculosis Elimination and HIV/AIDS Special Studies Branch before assuming his current position.
From page 444...
... Dr. Duchin is a member of the Infectious Disease Society of America's National and Global Public Health Committee and Pandemic Influenza Task Force and is past-Chair of their Bioemergencies Task Force.
From page 445...
... Feinberg and colleagues were engaged in the preclinical development and evaluation of novel vaccines for HIV and other infectious diseases and in basic research studies focused on revealing fundamen tal aspects of the pathogenesis of AIDS.
From page 446...
... Dr. Fletcher's research focuses on mechanisms of virulence and insect transmission of plant pathogenic bacteria; the relationships between human pathogens, such as Salmonella and Escherichia coli, and plants; and on the emerging disciplines of microbial forensics and agricultural biosecurity.
From page 447...
... He is an active clinician and teacher who is board certified in internal medicine, oncology, and infectious diseases and is staff physician and infectious diseases consultant at the National Naval and Walter Reed Army Medical Centers.
From page 448...
... ; the International Society for Infec tious Diseases (1996–1998) ; the PanAmerican Infectious Diseases Association; the International Federation for Tropical Medicine (2005–2008)
From page 449...
... , including bacterial, viral, parasitic, and prion diseases. DMID supports a wide variety of projects spanning the spectrum from basic biology of human pathogens and their interaction with human hosts, through translational and clinical research, toward the development of new and improved diagnostics, drugs, and vaccines for infectious diseases.
From page 450...
... Heymann, M.D., is currently chair of the Health Protection Agency, United Kingdom; professor and chair, infectious disease epidemiology, at the London School of Hygiene and Tropical Medicine; and head of the Global Health Security Programme at Chatham House, London. Until April 2009, he was assistant director-general for Health Security Environment and Representative of the director-general for Polio Eradication at WHO.
From page 451...
... Dr. Heymann has been visiting professor at Stanford University, the University of Southern California, and the George Washington University School of Public Health; has published over 145 scientific articles on infectious diseases and related issues in peerreviewed medical and scientific journals; and has authored several chapters on infectious diseases in medical textbooks.
From page 452...
... He currently is a member of the Steering Committee of the NIAID/Uniformed Services University of the Health Sciences Infectious Disease Clinical Research Program, as well as multiple NIAID Safety Monitor
From page 453...
... He has worked in the laboratory and in the field in Latin America, Africa, and Asia on basic and clinical infectious diseases and HIV/AIDS research. From 1998 to 2003, he was associate director for international research and director of the Fogarty International Center at NIH.
From page 454...
... King was instrumental in obtaining funds for the construction of a $60 million Diagnostic Center for Population and Animal Health, he initiated the Center for Emerging Infectious Diseases in the college, he served as the campus leader in food safety, and he had oversight for the National Food Safety and Toxicology Center.
From page 455...
... with honors from the University of Rochester. He completed postgraduate training in internal medicine and infectious diseases at the University of North Carolina, Chapel Hill, and is board certified in both.
From page 456...
... Delegation to the U.S.–Japan Cooperative Medical Sciences Program. He was co-chair of the NAS Committee on Advances in Technology and the Prevention of Their Application to Next Generation Biowarfare Threats, and he recently chaired an IOM study committee related to vaccines for the pro tection of the military against naturally occurring infectious disease threats.
From page 457...
... Dr. Miller is a reviewer for nine journals, including the Journal of Infectious Diseases, The Lancet, and the Journal of the American Public Health Association.
From page 458...
... He served as principal investigator for the CDC-sponsored Emerging Infections Program in Minnesota. He has published more than 300 articles and abstracts on various emerging infectious disease problems and is the author of the best-selling book Living Terrors: What America Needs to Know to Survive the Coming Bioterrorist Catastrophe.
From page 459...
... John C Pottage, Jr., M.D., has been vice president for Global Clinical Development in the Infectious Disease Medicine Development Center at GlaxoSmithKline since 2007.
From page 460...
... In addition, he is currently heading the Emerging Pathogens Initiative for the VA. He has received commendations from the under secretary for health for the VA and the secretary of VA for his work in the Infectious Diseases Program for the VA.
From page 461...
... He was stationed in Panama City, Florida, at the Experimental Diving Unit where he worked in diving medicine research from 1991 to 1995. After a preventive medicine residency with a Masters in tropical medicine and hygiene, he was transferred to Lima, Peru, where he became head of the Virology Laboratory.
From page 462...
... His work helped to define the genetics of antibiotic resistance in gonococci and the role of iron-scavenging systems in the pathogenesis of human gonorrhea. Current interests include pathogenesis of gonococcal infections and development of a vaccine for gonorrhea and managing a large multi-institution interactive research group focused on emerging infections and biodefense.
From page 463...
... from the University of Wisconsin and completed an internal medicine residency and infectious disease fellowship at the Beth Israel Hospital in Boston (now Beth Israel-Deaconess Medical Center)
From page 464...
... , senior editor, with Richard Levins and Andrew Spielman, of Disease in Evolution: Global Changes and Emergence of Infectious Diseases (New York Academy of Sciences, 1994) , and editor of the volume New and Emerging Infectious Diseases (Medical Clinics of North America)


This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.